US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist
  • 23.460
  • +0.390+1.69%
Close 02/23 16:00 ET
  • 23.460
  • 0.0000.00%
Post 18:14 ET
1.04BMarket Cap-16224P/E (TTM)

About Silence Therapeutics Company

Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.

Company Profile

SymbolSLN
Company NameSilence Therapeutics
Founded1994
CEOMr. Craig A. Tooman
MarketNASDAQ
Employees122
Securities TypeDR
ADS Ratio1.0 : 3.0
Fiscal Year Ends12-31
Address72 Hammersmith Road
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW14 8TH
Phone44-20-3457-6900

Company Executives

  • Name
  • Position
  • Salary
  • Craig A. Tooman
  • President, Chief Executive Officer and Executive Director
  • 2.45M
  • Dr. Giles Victor Campion
  • Executive Vice President, Head of R&D, Chief Medical Officer and Executive Director
  • 1.12M
  • Rhonda L. Hellums
  • Chief Financial Officer
  • 489.00K
  • Iain Gladstone Ross
  • Non-Executive Chairman of the Board
  • 120.00K
  • James Lawrence Ede-Golightly
  • Director
  • 55.00K
  • Dr. Steven Joseph Romano, M.D.
  • Director
  • 55.00K
  • David Jakob Lemus
  • Non-Executive Director
  • 55.00K
  • Alistair William Gray
  • Senior Independent Director
  • 55.00K
  • Dr. Michael Harvey Davidson, M.D.
  • Independent Director
  • 54.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg